yahoo Press
KeyBanc Raises its Price Target on American Healthcare REIT (AHR)
Images
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational. American Healthcare REIT, Inc. (NYSE:AHR) is one of the 15 Most Promising Stocks to Buy Right Now. On May 28, 2026, KeyBanc raised the firm’s price target on American Healthcare REIT, Inc. (NYSE:AHR) to $58 from $55 and maintained an Overweight rating on the shares. KeyBanc said American Healthcare REIT remains well-positioned to benefit from strength across its RIDEA segments and a fortified balance sheet following last week’s equity issuance. The firm also raised its 2026 NFFO estimate by about 5% to $2.11 per share and its 2027 NFFO estimate by 6% to $2.40 per share, citing upside to the company’s 2026 SSNOI growth outlook, earnings accretion from awarded acquisitions, and a robust investment pipeline. On May 26, 2026, RBC Capital analyst Michael Carroll raised the firm’s price target on American Healthcare REIT, Inc. (NYSE:AHR) to $56 from $54 and maintained an Outperform rating on the shares. Carroll said the company delivered a solid earnings report, highlighted by healthy organic growth and an attractive investment pace. Earlier in May, American Healthcare REIT, Inc. (NYSE:AHR) reported Q1 normalized FFO of 50c, ahead of the consensus estimate of 47c. Revenue totaled $650.77M, below the consensus estimate of $687.04M. CEO Jeff Hanson said the quarter reflected an “exceptionally strong period” across core metrics, including the company’s ninth consecutive quarter of double-digit Same-Store NOI growth, efficient capital formation and deployment, a strengthened balance sheet, and a raise to full-year 2026 Same-Store NOI growth and NFFO per share guidance. American Healthcare REIT, Inc. (NYSE:AHR) owns and operates a diversified portfolio of clinical healthcare real estate. While we acknowledge the potential of AHR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Disclosure: None. Follow Insider Monkey on Google News.
Comments
You must be logged in to comment.